MA23837A1 - Benzamides pour le traitement de degenerescenses neurologiques - Google Patents

Benzamides pour le traitement de degenerescenses neurologiques

Info

Publication number
MA23837A1
MA23837A1 MA24193A MA24193A MA23837A1 MA 23837 A1 MA23837 A1 MA 23837A1 MA 24193 A MA24193 A MA 24193A MA 24193 A MA24193 A MA 24193A MA 23837 A1 MA23837 A1 MA 23837A1
Authority
MA
Morocco
Prior art keywords
degeneres
benzamides
neurological
treatment
neurological degeneres
Prior art date
Application number
MA24193A
Other languages
English (en)
Inventor
D Filter W
L Wilcox A
A Garland W
E Raylod R
Original Assignee
Centaur Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/415,248 external-priority patent/US5659082A/en
Priority claimed from US08/415,847 external-priority patent/US5643965A/en
Priority claimed from US08/415,694 external-priority patent/US5658953A/en
Application filed by Centaur Pharmaceuticals Inc filed Critical Centaur Pharmaceuticals Inc
Publication of MA23837A1 publication Critical patent/MA23837A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/38Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
MA24193A 1995-04-03 1996-04-01 Benzamides pour le traitement de degenerescenses neurologiques MA23837A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41567795A 1995-04-03 1995-04-03
US08/415,248 US5659082A (en) 1995-04-03 1995-04-03 Nitro- and aminobenzamide compounds for neurodegenerative disorders
US08/415,847 US5643965A (en) 1995-04-03 1995-04-03 Aminobenzamide compounds for the treatment of neurodegenerative disorders
US08/415,694 US5658953A (en) 1995-04-03 1995-04-03 Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders

Publications (1)

Publication Number Publication Date
MA23837A1 true MA23837A1 (fr) 1996-12-31

Family

ID=27503636

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24193A MA23837A1 (fr) 1995-04-03 1996-04-01 Benzamides pour le traitement de degenerescenses neurologiques

Country Status (39)

Country Link
EP (1) EP0819113B1 (fr)
JP (1) JP3479658B2 (fr)
KR (1) KR100429120B1 (fr)
CN (1) CN1073552C (fr)
AR (1) AR002978A1 (fr)
AT (1) ATE202552T1 (fr)
AU (1) AU721045B2 (fr)
BG (1) BG63384B1 (fr)
CA (1) CA2215166A1 (fr)
CO (1) CO4700431A1 (fr)
CZ (1) CZ295852B6 (fr)
DE (1) DE69613567T2 (fr)
DK (1) DK0819113T3 (fr)
DZ (1) DZ2012A1 (fr)
EA (1) EA002031B1 (fr)
EE (1) EE03437B1 (fr)
ES (1) ES2160240T3 (fr)
GR (1) GR3036466T3 (fr)
HK (1) HK1016964A1 (fr)
HR (1) HRP960156B1 (fr)
HU (1) HUP9801759A3 (fr)
IL (1) IL117629A (fr)
IS (1) IS1919B (fr)
MA (1) MA23837A1 (fr)
MX (1) MX9707596A (fr)
MY (1) MY121206A (fr)
NO (1) NO318441B1 (fr)
NZ (1) NZ306204A (fr)
PL (1) PL184121B1 (fr)
PT (1) PT819113E (fr)
RO (1) RO116190B1 (fr)
SA (1) SA96160739B1 (fr)
SI (1) SI0819113T1 (fr)
SK (1) SK282900B6 (fr)
TN (1) TNSN96051A1 (fr)
TR (1) TR199701114T1 (fr)
TW (1) TW381073B (fr)
WO (1) WO1996031462A1 (fr)
YU (1) YU21096A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW412421B (en) * 1996-04-17 2000-11-21 Centaur Pharmaceuticals Inc Benzamide treatment of dementia associated with AIDS virus (HIV-1) infection
WO1999021543A1 (fr) * 1997-10-27 1999-05-06 Sumitomo Pharmaceuticals Co., Ltd. Derives d'amide
CA2332398A1 (fr) 1998-05-19 1999-11-25 Ian Irwin Medicament a base de benzamide, destine au traitement des affections inflammatoires de l'intestin
EP1077699A1 (fr) * 1998-05-19 2001-02-28 Centaur Pharmaceuticals, Inc. Medicament a base d'amide, destine au traitement des affections inflammatoires de l'intestin
WO2000064430A1 (fr) * 1999-04-23 2000-11-02 Sumitomo Pharmaceuticals Co., Ltd. Inhibiteurs de l'apoptose
CN101817761B (zh) * 2010-01-29 2014-06-25 浙江大学 苯甲酸酯类衍生物及制备方法和应用
WO2011099502A1 (fr) * 2010-02-10 2011-08-18 公立大学法人横浜市立大学 Utilisation d'un composé se liant à msin3b qui se lie, de façon spécifique, au facteur silenceur de la spécification neuronale nrsf
WO2014155184A1 (fr) * 2013-03-28 2014-10-02 Rhenovia Pharma Traitement pour maladie de parkinson
CN115594603A (zh) * 2022-10-09 2023-01-13 湖北师范大学(Cn) 微通道反应器制备n-叔丁基-4-氨基苯甲酰胺的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1069882B (it) * 1975-12-22 1985-03-25 Mallinckrodt Inc 3 5 bis acilammino benzammidi particolarmente utili come agenti di contrasto per raffi x e procedimento per la loro preparazione
JPS5721320A (en) * 1980-07-11 1982-02-04 Chugai Pharmaceut Co Ltd Blood sugar level depressing agent
JPS5867657A (ja) * 1981-10-15 1983-04-22 Chugai Pharmaceut Co Ltd ペンズアミド誘導体
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions

Also Published As

Publication number Publication date
KR19980703562A (ko) 1998-11-05
CZ295852B6 (cs) 2005-11-16
JPH11501319A (ja) 1999-02-02
AU721045B2 (en) 2000-06-22
HUP9801759A2 (hu) 1998-12-28
SA96160739B1 (ar) 2005-10-15
NZ306204A (en) 1999-01-28
MX9707596A (es) 1998-06-30
CN1182416A (zh) 1998-05-20
EP0819113B1 (fr) 2001-06-27
IL117629A (en) 2000-08-13
HRP960156A2 (en) 1997-10-31
EA002031B1 (ru) 2001-12-24
CN1073552C (zh) 2001-10-24
KR100429120B1 (ko) 2004-08-18
IS1919B (is) 2004-03-15
TNSN96051A1 (fr) 2005-03-15
NO318441B1 (no) 2005-03-21
GR3036466T3 (en) 2001-11-30
MY121206A (en) 2006-01-28
EA199700287A1 (ru) 1998-04-30
PT819113E (pt) 2001-10-30
TR199701114T1 (xx) 1998-02-21
ATE202552T1 (de) 2001-07-15
BG101929A (en) 1998-04-30
DZ2012A1 (fr) 2002-07-21
DE69613567T2 (de) 2002-04-18
SI0819113T1 (en) 2001-10-31
BG63384B1 (bg) 2001-12-29
PL184121B1 (pl) 2002-09-30
JP3479658B2 (ja) 2003-12-15
IS4569A (is) 1997-09-25
NO974569D0 (no) 1997-10-02
WO1996031462A1 (fr) 1996-10-10
HUP9801759A3 (en) 2001-06-28
RO116190B1 (ro) 2000-11-30
IL117629A0 (en) 1996-07-23
HRP960156B1 (en) 2002-04-30
SK282900B6 (sk) 2003-01-09
CZ309897A3 (cs) 1998-12-16
TW381073B (en) 2000-02-01
EE03437B1 (et) 2001-06-15
PL322625A1 (en) 1998-02-02
CA2215166A1 (fr) 1996-10-10
ES2160240T3 (es) 2001-11-01
SK132597A3 (en) 1998-09-09
NO974569L (no) 1997-11-21
DE69613567D1 (de) 2001-08-02
CO4700431A1 (es) 1998-12-29
YU21096A (sh) 1999-03-04
HK1016964A1 (en) 1999-11-12
EP0819113A1 (fr) 1998-01-21
AR002978A1 (es) 1998-05-27
EE9700235A (et) 1998-04-15
AU5440496A (en) 1996-10-23
DK0819113T3 (da) 2001-10-15

Similar Documents

Publication Publication Date Title
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
NO961483L (no) Fremgangsmåte for behandling av oljeholdig formasjon
DE59608738D1 (de) Verwendung von epinastin für die behandlung von schmerzen
ZA9610139B (en) Treatment of the cns effects of hiv
NO963785D0 (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
FR2663044B1 (fr) Appareil pour le traitement de surfaces.
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69627414D1 (de) Zusammensetzung effektiv für die Entfernung von Asphalten
FR2705966B1 (fr) Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
IL119459A0 (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
MA23837A1 (fr) Benzamides pour le traitement de degenerescenses neurologiques
FR2694575B1 (fr) Procede pour le traitement de revetements en mcralz.
FR2758465B1 (fr) Composition pour le traitement de l'amiante
EP0828503A4 (fr) Traitement destine a inhiber la progression de maladies auto-immunes
FR2746658B1 (fr) Valve de drainage implantable pour le traitement de l'hydrocephalie
FR2694384B1 (fr) Traitement de la surface de réfractaires.
FR2728142B1 (fr) Composition pour le traitement anti-germinatif de tubercules ou de bulbes ; procede de traitement
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.
FR2719240B1 (fr) Procédé de traitement des suspensions huileuses.
NO982562D0 (no) Sammensetning for behandling av smerte
FR2751637B1 (fr) Cellule d'electrocoagulation pour le traitement d'effluents
FR2751544B1 (fr) Composition therapeutique pour le traitement des verrues vulgaires